{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-08-27",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 2
    }
  },
  "results": [
    {
      "discontinued_date": "03/19/2026",
      "update_type": "New",
      "initial_posting_date": "03/19/2026",
      "package_ndc": "64764-805-10",
      "generic_name": "Ramelteon Tablet",
      "contact_info": "877-825-3327",
      "related_info": "Product is expected to be available through February 2027.",
      "openfda": {
        "application_number": [
          "NDA021782"
        ],
        "brand_name": [
          "ROZEREM"
        ],
        "generic_name": [
          "RAMELTEON"
        ],
        "manufacturer_name": [
          "Takeda Pharmaceuticals America, Inc."
        ],
        "product_ndc": [
          "64764-805"
        ],
        "product_type": [
          "HUMAN PRESCRIPTION DRUG"
        ],
        "route": [
          "ORAL"
        ],
        "substance_name": [
          "RAMELTEON"
        ],
        "rxcui": [
          "577348",
          "603162"
        ],
        "spl_id": [
          "2021e7fb-108a-4783-9a37-8bc05bf28b28"
        ],
        "spl_set_id": [
          "9de82310-70e8-47b9-b1fc-6c6848b99455"
        ],
        "package_ndc": [
          "64764-805-30",
          "64764-805-10",
          "64764-805-22"
        ],
        "nui": [
          "N0000175743",
          "N0000000250"
        ],
        "pharm_class_epc": [
          "Melatonin Receptor Agonist [EPC]"
        ],
        "pharm_class_moa": [
          "Melatonin Receptor Agonists [MoA]"
        ],
        "unii": [
          "901AS54I69"
        ]
      },
      "update_date": "03/19/2026",
      "therapeutic_category": [
        "Psychiatry"
      ],
      "dosage_form": "Tablet",
      "presentation": "Rozerem, Tablet, 8 mg (NDC 64764-805-10)",
      "company_name": "Takeda Pharmaceuticals USA Inc.",
      "status": "To Be Discontinued"
    }
  ]
}